Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 5
2009 5
2010 3
2011 1
2012 1
2013 4
2014 4
2015 1
2016 2
2017 5
2018 5
2019 6
2020 8
2021 10
2022 5
2023 5
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote V, Shpilberg O, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Celli M, Hess G, Arcaini L, Visco C, van Meerten T, Wirths S, Zinzani PL, Novak U, Herhaus P, Benedetti F, Sonnevi K, Hanoun C, Hänel M, Dierlamm J, Pott C, Klapper W, Gözel D, Schmidt C, Unterhalt M, Ladetto M, Hoster E. Dreyling M, et al. Among authors: vergote v. Lancet. 2024 May 25;403(10441):2293-2306. doi: 10.1016/S0140-6736(24)00184-3. Epub 2024 May 2. Lancet. 2024. PMID: 38705160 Free article. Clinical Trial.
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.
Sanchez-Felipe L, Vercruysse T, Sharma S, Ma J, Lemmens V, Van Looveren D, Arkalagud Javarappa MP, Boudewijns R, Malengier-Devlies B, Liesenborghs L, Kaptein SJF, De Keyzer C, Bervoets L, Debaveye S, Rasulova M, Seldeslachts L, Li LH, Jansen S, Yakass MB, Verstrepen BE, Böszörményi KP, Kiemenyi-Kayere G, van Driel N, Quaye O, Zhang X, Ter Horst S, Mishra N, Deboutte W, Matthijnssens J, Coelmont L, Vandermeulen C, Heylen E, Vergote V, Schols D, Wang Z, Bogers W, Kuiken T, Verschoor E, Cawthorne C, Van Laere K, Opdenakker G, Vande Velde G, Weynand B, Teuwen DE, Matthys P, Neyts J, Jan Thibaut H, Dallmeier K. Sanchez-Felipe L, et al. Among authors: vergote v. Nature. 2021 Feb;590(7845):320-325. doi: 10.1038/s41586-020-3035-9. Epub 2020 Dec 1. Nature. 2021. PMID: 33260195
The evolutionary history of hepaciviruses.
Li YQ, Ghafari M, Holbrook AJ, Boonen I, Amor N, Catalano S, Webster JP, Li YY, Li HT, Vergote V, Maes P, Chong YL, Laudisoit A, Baelo P, Ngoy S, Mbalitini SG, Gembu GC, Musaba AP, Goüy de Bellocq J, Leirs H, Verheyen E, Pybus OG, Katzourakis A, Alagaili AN, Gryseels S, Li YC, Suchard MA, Bletsa M, Lemey P. Li YQ, et al. Among authors: vergote v. bioRxiv [Preprint]. 2023 Jun 30:2023.06.30.547218. doi: 10.1101/2023.06.30.547218. bioRxiv. 2023. PMID: 37425679 Free PMC article. Preprint.
Management of post-transplant lymphoproliferative disorders.
Dierickx D, Vergote V. Dierickx D, et al. Among authors: vergote v. Hemasphere. 2019 Jun 30;3(Suppl):74-77. doi: 10.1097/HS9.0000000000000226. eCollection 2019 Jun. Hemasphere. 2019. PMID: 35309814 Free PMC article. No abstract available.
Hantaviridae: Current Classification and Future Perspectives.
Laenen L, Vergote V, Calisher CH, Klempa B, Klingström J, Kuhn JH, Maes P. Laenen L, et al. Among authors: vergote v. Viruses. 2019 Aug 27;11(9):788. doi: 10.3390/v11090788. Viruses. 2019. PMID: 31461937 Free PMC article.
Design and validation of a laboratory-developed diagnostic assay for monkeypox virus.
Sklenovská N, Bloemen M, Vergote V, Logist AS, Vanmechelen B, Laenen L, André E, Muyembe-Tamfum JJ, Wollants E, Van Ranst M, Maes P, Wawina-Bokalanga T. Sklenovská N, et al. Among authors: vergote v. Virus Genes. 2023 Dec;59(6):795-800. doi: 10.1007/s11262-023-02024-9. Epub 2023 Aug 17. Virus Genes. 2023. PMID: 37589804 Free PMC article.
Not all black colons on [18F]FDG PET are due to metformin.
Boeckxstaens L, Vergote V, Dierickx D, Tousseyn T, Bielen D, Van Laere K, Deroose CM, Goffin K. Boeckxstaens L, et al. Among authors: vergote v. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3477-3478. doi: 10.1007/s00259-023-06269-2. Epub 2023 May 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 37233784 No abstract available.
65 results